Eduardo M. Castaño

β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

Claudio Soto, Einar M. Sigurdsson, Laura Morelli et al. · Nature Medicine · 1998 · 868 citations

Life Sciences, Biochemistry, Neuroscience +14

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Eduardo M. Castaño, Adam A. Golabek, Thomas Vogel et al. · PubMed · 1994 · 444 citations

Life Sciences, Biochemistry, Molecular Biology +13

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

Alex E. Roher, Chera L. Esh, Tyler A. Kokjohn et al. · Alzheimer s & Dementia · 2008 · 410 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Itziar de Rojas, Sonia Moreno–Grau, Niccoló Tesi et al. · Nature Communications · 2021 · 338 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The α-Helical to β-Strand Transition in the Amino-terminal Fragment of the Amyloid β-Peptide Modulates Amyloid Formation

Claudio Soto, Eduardo M. Castaño, Blas Frangione et al. · Journal of Biological Chemistry · 1995 · 321 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17